Ares Capital Corporation's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Interest-Expense" stands at 803.00 Million United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026, the highest value at least since 12/31/2012, the period currently displayed.
Ares Capital Corporation's second quarter result of 214.00 Million USD for the item "Interest Expense" represents an increase of 8.08 percent compared to it's first quarter result.
Also, Ares Capital Corporation's second quarter result of 214.00 Million USD for the item "Interest Expense" represents an increase of 24.42 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Ares Capital Corporation's second quarter result of 803.00 Million USD for the item "Interest Expense" represents an increase of 5.52 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 14.88 percent compared to the value the year prior.
The 1 year change in percent is 14.88.
The 3 year change in percent is 64.55.
The 5 year change in percent is 179.79.
The 10 year change in percent is 303.58.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Berkshire Hathaway Inc - Interest Expense | 1,088,030,244,864.00 |
![]() | Blackstone Group Inc - Interest Expense | 186,696,990,720.00 |
![]() | BlackRock Inc - Interest Expense | 166,346,604,544.00 |
![]() | KKR & Co LP - Interest Expense | 119,832,821,760.00 |
![]() | BioPharma Credit PLC - Interest Expense | 101,856,345,600.00 |